We were particularly interested in studying those genes that are associated with cancer progression, TME signals, and poor prognosis such as LY6E [38], NAPSA [39], MUC1 [40, 41], ELF3 [42, 43], and FOS [44] (Fig. 5b). This evidence concerns the gene LY6E and cancer.